HAL Allergy Group Overview

  • Founded
  • 1959
Founded
  • Status
  • Private
  • Employees
  • 300
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 2

HAL Allergy Group General Information

Description

Developer and manufacturer of therapeutic and diagnostic agents focused on allergen immunotherapy. The company develops and produces vaccines, allergy detection and treatment products used for therapeutic and diagnostic purposes, against common allergies such as hay fever, house dust mites allergy and allergic reactions towards wasp or bee stings.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • J.H. Oortweg 15-17
  • 2333 CH Leiden
  • Netherlands
+31 088 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HAL Allergy Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HAL Allergy Group‘s full profile, request access.

Request a free trial

HAL Allergy Group Executive Team (7)

Name Title Board Seat Contact Info
Harry Flore Chief Executive Officer
Florian Rösch Chief Commercial & Financial Officer & Board Member
Eize de Boer Ph.D Chief Operating Officer & Board Member
Hans van Schijndel Ph.D Chief Research & Development Officer
Johan Kuijper Founder
You’re viewing 5 of 7 executive team members. Get the full list »

HAL Allergy Group Board Members (3)

Name Representing Role Since
0000 00 0000 00.0 HAL Allergy Group Chief Operating Officer & Board Member 000 0000
0000000 0ö000 HAL Allergy Group Chief Commercial & Financial Officer & Board Member 000 0000
To view HAL Allergy Group’s complete board members history, request access »

HAL Allergy Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HAL Allergy Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HAL Allergy Group‘s full profile, request access.

Request a free trial